About Eumentis Therapeutics
Eumentis Therapeutics is a private company based in Newton, Massachusetts, incorporated in 2019 in Delaware. It has reported $11,265,000 raised in four offerings on Form D since September 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 16, 2021 | Jun 26, 2024 | $765,000of $2.0M target | 11 | $69,545 | Debt, OptionsRule 506(b) | Form D ↗ |
| Not yet | Mar 17, 2023 | $4,000,000of $20.0M target | 1 | $4.0M | DebtRule 506(b) | Form D ↗ |
| Apr 13, 2022 | Apr 15, 2022 | $5,000,000fully sold | 1 | $5.0M | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 14, 2018 | Sep 2, 2020 | $1,500,000of $3.3M target | 25 | $60,000 | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $11,265,000 | |||||
The filing for the offering first filed Mar 17, 2023 reports amount sold but first sale marked as not yet made. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Eumentis Therapeutics's Form D filed Jun 26, 2024.
MB
Maryann Bryla
Director
JL
James Larrick
Director
RM
Randall Marshall
Executive officer
KP
Kim Patrick
Director
MT
Mark Tepper
President and director
AP
Andrew Pearlman
Director
Earlier filings also listed Amar Kapur (director, last listed Apr 2022).